IAS
INR Advisory Services Portfolio holdings
AUM
$786M
This Quarter Return
+0.24%
1 Year Return
+2.23%
3 Year Return
+21.88%
5 Year Return
+25.06%
10 Year Return
–
AUM
$727M
AUM Growth
+$727M
(+0.05%)
Cap. Flow
-$510K
Cap. Flow
% of AUM
-0.07%
Top 10 Holdings %
Top 10 Hldgs %
99.72%
Holding
131
New
59
Increased
15
Reduced
11
Closed
13
Top Buys
| 1 |
Vanguard Total Bond Market
BND
|
$419K |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
$373K |
| 3 |
SPDR Portfolio S&P 500 ETF
SPLG
|
$96.1K |
| 4 |
SPDR Portfolio Developed World ex-US ETF
SPDW
|
$67.1K |
| 5 |
SAP
SAP
|
$56K |
Top Sells
| 1 |
Vanguard Growth ETF
VUG
|
$992K |
| 2 |
Vanguard Small-Cap ETF
VB
|
$395K |
| 3 |
Vanguard Mid-Cap ETF
VO
|
$231K |
| 4 |
Vanguard FTSE All-World ex-US ETF
VEU
|
$113K |
| 5 |
Vanguard Value ETF
VTV
|
$24.7K |
Sector Composition
| 1 | Consumer Staples | 0.05% |
| 2 | Financials | 0.03% |
| 3 | Healthcare | 0.02% |
| 4 | Technology | 0.01% |
| 5 | Energy | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Teva Pharmaceuticals
TEVA
$21.5B
| $4K | ﹤0.01% |
+154
| New | +$4K |
|
52
Apple
AAPL
$3.41T
| $3K | ﹤0.01% |
+16
| New | +$3K |
|
53
AstraZeneca
AZN
$249B
| $3K | ﹤0.01% |
+94
| New | +$3K |
|
54
Barclays
BCS
$68.7B
| $3K | ﹤0.01% |
+292
| New | +$3K |
|
55
B&G Foods
BGS
$349M
| $3K | ﹤0.01% |
+89
| New | +$3K |
|
56
Ford
F
$46.6B
| $3K | ﹤0.01% |
+241
| New | +$3K |
|
57
General Motors
GM
$55.7B
| $3K | ﹤0.01% |
+80
| New | +$3K |
|
58
Hanesbrands
HBI
$2.16B
| $3K | ﹤0.01% |
+155
| New | +$3K |
|
59
HSBC
HSBC
$222B
| $3K | ﹤0.01% |
+68
| New | +$3K |
|
60
Intel
INTC
$106B
| $3K | ﹤0.01% |
+60
| New | +$3K |
|
61
International Paper
IP
$26B
| $3K | ﹤0.01% |
+52
| New | +$3K |
|
62
JPMorgan Chase
JPM
$824B
| $3K | ﹤0.01% |
+28
| New | +$3K |
|
63
Kimberly-Clark
KMB
$42.7B
| $3K | ﹤0.01% |
+30
| New | +$3K |
|
64
Lloyds Banking Group
LYG
$63.6B
| $3K | ﹤0.01% |
+789
| New | +$3K |
|
65
Mattel
MAT
$5.84B
| $3K | ﹤0.01% |
+188
| New | +$3K |
|
66
MetLife
MET
$53.6B
| $3K | ﹤0.01% |
+65
| New | +$3K |
|
67
Merck
MRK
$214B
| $3K | ﹤0.01% |
+57
| New | +$3K |
|
68
PepsiCo
PEP
$206B
| $3K | ﹤0.01% |
+29
| New | +$3K |
|
69
Pfizer
PFE
$142B
| $3K | ﹤0.01% |
+76
| New | +$3K |
|
70
Phillips 66
PSX
$54.1B
| $3K | ﹤0.01% |
+28
| New | +$3K |
|
71
Qualcomm
QCOM
$171B
| $3K | ﹤0.01% |
+53
| New | +$3K |
|
72
AT&T
T
$208B
| $3K | ﹤0.01% |
+87
| New | +$3K |
|
73
Wells Fargo
WFC
$262B
| $3K | ﹤0.01% |
+57
| New | +$3K |
|
|
AMTD
74
DELISTED
TD Ameritrade Holding Corp
AMTD
| $3K | ﹤0.01% |
56
| – | – |
|
|
RDS.A
75
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $2K | ﹤0.01% |
+23
| New | +$2K |
|